Evidence map›Paper›PMID 37213669›Full record

ArticleInternational journal of medical sciences2023

Role of the gut microbiota and their metabolites in hemodialysis patients.

Ying Ting Chao, Ying-Kuang Lin, Liang-Kun Chen, Poyin Huang, Yi-Chiung Hsu

Open access · goldAbstract read
In one paragraph

Article in International journal of medical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Dietary Guidelines Post Kidney Transplant: Is This the Missing Link in Recovery and Graft Survival?Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Review
  9. Review
  10. Article
  11. Gut Microbiota in Patients Receiving Dialysis: A Review.Pathogens (Basel, Switzerland) · 2024
    Review
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ying Ting ChaoDepartment of Biomedical Sciences and Engineering, National Central University, Taoyuan 320317, Taiwan, R.O.C.
Ying-Kuang LinDepartment of Biomedical Sciences and Engineering, National Central University, Taoyuan 320317, Taiwan, R.O.C.
Liang-Kun ChenDepartment of Biomedical Sciences and Engineering, National Central University, Taoyuan 320317, Taiwan, R.O.C.
Poyin HuangDepartment of Neurology, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung City, 807, Taiwan, R.O.C.
Yi-Chiung HsuDepartment of Biomedical Sciences and Engineering, National Central University, Taoyuan 320317, Taiwan, R.O.C.
National Central University · TWKaohsiung Medical University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High serum phosphate levels in chronic kidney disease (CKD) are linked to adverse health outcomes, including cardiovascular disease, kidney disease progression, and all-cause mortality. This study is aimed to find out which microorganisms or microbial functions have a significant impact on higher calcium-phosphorus product (Ca x P) after they undergo hemodialysis (HD) treatment.

Indexed as

Gastrointestinal MicrobiomeRenal Insufficiency, ChronicFecesHumansKidneyRenal Dialysiscalcium-phosphorus productchronic kidney diseasedysbiosisgut microbiota

Identifiers

PMID37213669
PMCPMC10198149
OpenAlexW4377221060

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.